Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |